Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 190, Issue -, Pages 165-173Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2016.06.010
Keywords
Eclipta prostrata I.; Learning and memory; Long-term potentiation; Protein kinase b; Glycogen synthase kinase 313
Categories
Funding
- High Value-Added Food Technology Development Program, Korea Institute of Planning and Evaluation for Technology in Food Agriculture, Forestry and Fisheries [113036-04-1-HD020]
Ask authors/readers for more resources
Ethnopharmacological relevance: Eclipta prostrata L (Asteraceae) has been prescribed for whole body nourishment and nervine tonic in Asia. However, the effects of E. prostrata in learning and memory have not been fully explored. Aim of the study: To scientifically elucidate the effects of E. prostrata on cognitive functions, we examined whether E. prostrata could ameliorate a cholinergic blockade-induced memory impairment, and we also investigated the effects of E. prostrata on the synaptic plasticity in the hippocampus. Materials and methods: Memory impairment was induced by scopolamine, a cholinergic muscarinic receptor antagonist. The anti-amnesic effects of the ethanolic extract of Eclipta prostrata L. (EEEP) were measured in mice by the passive avoidance, Y-maze and Morris water maze tasks. To test the effects of EEEP on synaptic plasticity, we measured long-term potentiation (LTP) in the hippocampus. We also studied several signaling molecules related to learning and memory, such as phosphorylated protein kinase B (Akt) or phosphorylated glycogen synthase kinase-3 beta (GSK-3 beta). Results: In the passive avoidance task, EEEP (50 or 100 mg/kg, p.o.) significantly ameliorated the shortened step-through latency induced by scopolamine. EEEP (100 mg/kg, p.o.) also showed significant increase in alternation behavior during the Y-maze task. In the Morris water maze task, scopolamine induced a decrease in both the swimming time within the target zone and the number of crossings where the platform had been placed were significantly reversed by EEEP (50 or 100 mg/kg, p.o.). Moreover, EEEP (100 mu g/ml) significantly enhanced hippocampal LTP without affecting basal synaptic transmission. The administration of EEEP (100 mg/kg) increased the phosphorylation levels of Akt and GSK-3 beta in the hippocampal region. Conclusion: These results suggest that EEEP has memory-ameliorating activity against scopolamine-induced cognitive impairment and facilitates LTP in the hippocampus. This could be, at least in part, mediated by the activation of the Akt-GSK-3 beta signaling pathway. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available